Literature DB >> 16423262

Biology of alveolar type II cells.

Robert J Mason1.   

Abstract

The purpose of this review is to highlight the many metabolic properties of alveolar type II cells, their production of surfactant, their role in innate immunity, and their importance in the repair process after lung injury. The review is based on the medical literature and results from our laboratory. Type II cells produce and secrete pulmonary surfactant and for that purpose they need to synthesize the lipids of surfactant. One of the regulators of lipogenesis is the transcription factor sterol regulatory element binding protein-1c (SREBP-1c). This is a key transcription factor regulating fatty acid synthesis. Type II cells also proliferate to restore the epithelium after lung injury, clear alveolar fluid by transporting sodium from the apical to the basolateral surface, and participate in the innate immune response to inhaled materials and organisms. The type II cell is, in many ways, the defender of the alveolus. However, the type II cells work in concert with the other cells in the gas exchange regions of the lung to keep the alveoli open and reduce inflammation due to irritants in the air we breathe.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16423262     DOI: 10.1111/j.1440-1843.2006.00800.x

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  141 in total

Review 1.  Innate Immune Signaling Activated by MDR Bacteria in the Airway.

Authors:  Dane Parker; Danielle Ahn; Taylor Cohen; Alice Prince
Journal:  Physiol Rev       Date:  2016-01       Impact factor: 37.312

2.  Alveolar type II cells maintain bioenergetic homeostasis in hypoxia through metabolic and molecular adaptation.

Authors:  Robyn G Lottes; Danforth A Newton; Demetri D Spyropoulos; John E Baatz
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-03-28       Impact factor: 5.464

3.  Age-Dependent Changes in AMPK Metabolic Pathways in the Lung in a Mouse Model of Hemorrhagic Shock.

Authors:  Lindsey R Klingbeil; Paul Kim; Giovanna Piraino; Michael O'Connor; Paul W Hake; Vivian Wolfe; Basilia Zingarelli
Journal:  Am J Respir Cell Mol Biol       Date:  2017-05       Impact factor: 6.914

4.  Age-related increases in ozone-induced injury and altered pulmonary mechanics in mice with progressive lung inflammation.

Authors:  Angela M Groves; Andrew J Gow; Christopher B Massa; LeRoy Hall; Jeffrey D Laskin; Debra L Laskin
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-08-30       Impact factor: 5.464

5.  NF-κB inhibitors impair lung epithelial tight junctions in the absence of inflammation.

Authors:  Christina Ward; Barbara Schlingmann; Arlene A Stecenko; David M Guidot; Michael Koval
Journal:  Tissue Barriers       Date:  2015-04-03

6.  A role for diacylglycerol in annexin A7-mediated fusion of lung lamellar bodies.

Authors:  Avinash Chander; Xiao-Liang Chen; Devendra G Naidu
Journal:  Biochim Biophys Acta       Date:  2007-07-27

7.  Molecular composition of the alveolar lining fluid in the aging lung.

Authors:  Juan I Moliva; Murugesan V S Rajaram; Sabeen Sidiki; Smitha J Sasindran; Evelyn Guirado; Xueliang Jeff Pan; Shu-Hua Wang; Patrick Ross; William P Lafuse; Larry S Schlesinger; Joanne Turner; Jordi B Torrelles
Journal:  Age (Dordr)       Date:  2014-03-03

8.  A New Role for the Mitochondrial Pro-apoptotic Protein SMAC/Diablo in Phospholipid Synthesis Associated with Tumorigenesis.

Authors:  Avijit Paul; Yakov Krelin; Tasleem Arif; Rina Jeger; Varda Shoshan-Barmatz
Journal:  Mol Ther       Date:  2017-12-24       Impact factor: 11.454

9.  Exploiting cellular-developmental evolution as the scientific basis for preventive medicine.

Authors:  J S Torday; V K Rehan
Journal:  Med Hypotheses       Date:  2009-01-14       Impact factor: 1.538

10.  Transplantation of human embryonic stem cell-derived alveolar epithelial type II cells abrogates acute lung injury in mice.

Authors:  Dachun Wang; John E Morales; Daniel G Calame; Joseph L Alcorn; Rick A Wetsel
Journal:  Mol Ther       Date:  2010-01-19       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.